Search

Displaying results 7191 - 7200 of 8573 in total
  1. Drug

    Ripazepam

    go.drugbank.com/drugs/DB20375
    Experimental

    Ripazepam has a monoisotopic molecular weight of 268.13 Da.

  2. Drug

    Piragliatin

    go.drugbank.com/drugs/DB20515
    Experimental

    Piragliatin has a monoisotopic molecular weight of 421.09 Da.

  3. Drug

    Siltenzepine

    go.drugbank.com/drugs/DB20589
    Experimental

    Siltenzepine has a monoisotopic molecular weight of 389.11 Da.

  4. Drug

    Ruzadolane

    go.drugbank.com/drugs/DB21444
    Experimental

    Ruzadolane has a monoisotopic molecular weight of 375.13 Da.

  5. Drug

    Mepiprazole

    go.drugbank.com/drugs/DB09197
    Experimental

    It acts as a 5-HT2A and α1-adrenergic receptor antagonist, and has also been shown to inhibit the reuptake and induce the release of serotonin, dopamine, and norepinephrine to varying extents.

  6. Drug

    Dimethyl carbate

    go.drugbank.com/drugs/DB13204
    Experimental

    Dimethyl carbate is used as an insect repellant.

  7. Drug

    Lubiprostone

    go.drugbank.com/drugs/DB01046
    ApprovedInvestigational

    Lubiprostone is a medication used in the management of idiopathic chronic constipation. A prostaglandin E1 derivative, lubiprostone is a bicyclic fatty acid that activates ClC-2 chloride channels located on the apical side of the gastroi...

  8. Drug

    Human Menstrual Blood-derived Stem Cells

    go.drugbank.com/drugs/DB15738
    Investigational

    MenSCs are special compared to older methods of adult stem cell extraction such as bone marrow stem cell extraction because MenSC extraction is a non-invasive method.

  9. Drug

    AM103

    go.drugbank.com/drugs/DB05225
    Experimental

    AM103 is a novel inhibitor of 5-lipoxygenase-activiting protein (FLAP) that has demonstrated potential to treat asthma and cardiovascular disease by preventing the synthesis of LT, which triggers inflammation

  10. Drug

    Emricasan

    go.drugbank.com/drugs/DB05408
    Investigational

    Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA.